IHME logo

Lisa Force

Assistant Professor

Lisa Force, MD, MPH, is an Assistant Professor in Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) and an Assistant Professor in the Department of Pediatrics, Division of Pediatric Hematology/Oncology, at the University of Washington School of Medicine. At IHME, she leads cancer modeling for the institute’s Global Burden of Disease (GBD) Study and her research interests include global pediatric oncology, global cancer epidemiology, and cancer disparities. She believes in health equity and cultural humility.

Dr. Force earned her undergraduate degree at the University of Oregon, her medical degree at the Boston University School of Medicine, and her MPH degree with a focus in epidemiology from the Harvard T.H. Chan School of Public Health. She completed a clinical residency in Pediatrics at the University of Washington/Seattle Children’s Hospital (UW/SCH) and fellowships in Pediatric Hematology/Oncology and Global Pediatric Medicine at St. Jude Children's Research Hospital. She has previously worked clinically caring for children with cancer, blood disorders, and HIV in Botswana and is currently an attending physician in Pediatric Hematology/Oncology at Seattle Children's Hospital.

IHME was established at the University of Washington in Seattle in 2007. Its mission is to deliver to the world timely, relevant, and scientifically valid evidence to improve health policy and practice.

Publications

Showing 1 - 5 of 13
GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 17 April 2024. doi: 10.1016/S0140-6736(24)00757-8.
GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting  the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology. 14 March 2024. doi:10.1016/S1474-4422(24)00038-3.
GBD US Health Disparities Collaborators. Burden of liver cancer mortality by county, race, and ethnicity in the USA, 2000–19: a systematic analysis of health disparities. The Lancet Public Health. 28 February 2024. doi: 10.1016/S2468-2667(24)00002-1.
GBD 2019 Lip, Oral, and Pharyngeal Cancer Collaborators. The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories. JAMA Oncology. 7 September 2023. doi: 10.1001/jamaoncol.2023.2960.
GBD US Health Disparities Collaborators. The burden of stomach cancer mortality by county, race, and ethnicity in the USA, 2000–2019: a systematic analysis of health disparities. The Lancet Regional Health - Americas. 4 August 2023. doi: 10.1016/j.lana.2023.100547.